Thalys Medical Technology Group Corporation (SHA:603716)

China flag China · Delayed Price · Currency is CNY
22.09
-0.95 (-4.12%)
Mar 19, 2026, 1:15 PM CST
Market Cap4.78B +131.1%
Revenue (ttm)1.25B -34.2%
Net Income-240.46M
EPS-1.26
Shares Out207.47M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,903,994
Average Volume14,392,191
Open22.80
Previous Close23.04
Day's Range22.05 - 22.81
52-Week Range8.10 - 38.12
Beta0.83
RSI49.51
Earnings DateApr 29, 2026

About SHA:603716

Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. It offers automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. The company also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. The company was formerly known as Thalys Medical Technology Inc. and changed ... [Read more]

Sector Healthcare
Founded 2004
Employees 1,246
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603716
Full Company Profile

Financial Performance

In 2024, SHA:603716's revenue was 1.81 billion, a decrease of -9.74% compared to the previous year's 2.01 billion. Losses were -209.24 million, 32.0% more than in 2023.

Financial Statements